Abstract 3414: PD-1 targeting increases the tolerance of IL-12 while maintaining potent anti-tumor immunity
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: Pfizer (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409630554
